Mitral repair and replacement devices and methods

Information

  • Patent Grant
  • 11951000
  • Patent Number
    11,951,000
  • Date Filed
    Thursday, August 4, 2022
    a year ago
  • Date Issued
    Tuesday, April 9, 2024
    21 days ago
Abstract
An implant and method for repairing and/or replacing functionality of a native mitral valve are in various embodiments configured to reduce or eliminate mitral regurgitation and residual mitral valve leakage. A coiled anchor can be used to implant a prosthetic valve in a native mitral valve of a heart. The coiled anchor can include a plurality of ventricular turns and one or more atrial turns. The coiled anchor is configured to be implanted at the native mitral valve with the plurality of ventricular turns positioned in a left ventricle of the heart and around valve leaflets of the native mitral valve. The plurality of ventricular turns are configured such that when a radially outward pressure is applied to at least one of the plurality of ventricular turns, the coiled anchor is biased such that a first diameter of a first turn of the plurality of ventricular turns is expanded and a second diameter of a second turn of the plurality of ventricular turns is reduced.
Description
BACKGROUND
Field

The invention generally relates to medical devices and procedures pertaining to heart valve repair and prosthetic heart valves. More specifically, the invention relates to repair and/or replacement of heart valves that have malformations or dysfunctions. Embodiments of the invention relate to devices and methods for reshaping or resizing the native mitral valve, further treatments for reducing residual leakage at the mitral valve annulus, and replacement of the functionality of the mitral valve with a prosthetic heart valve, for example, when leakage persists.


Description of Related Art

Referring first generally to FIGS. 1 and 2, the mitral valve controls the flow of blood between the left atrium and the left ventricle of the human heart. After the left atrium receives oxygenated blood from the lungs via the pulmonary veins, the mitral valve permits the flow of the oxygenated blood from the left atrium into the left ventricle. When the left ventricle contracts, the oxygenated blood held in the left ventricle is delivered through the aortic valve and the aorta to the rest of the body. Meanwhile, the mitral valve closes during ventricular contraction, to prevent the flow of blood back into the left atrium.


The mitral valve includes an anterior leaflet and a posterior leaflet. When the left ventricle contracts, the anterior and posterior leaflets come together and the blood pressure in the left ventricle increases substantially to urge the mitral valve closed. Due to the large pressure differential between the left ventricle and the left atrium during ventricular contraction, a possibility of prolapse, or eversion of the leaflets of the mitral valve back into the atrium, arises. To prevent this, a series of chordae tendineae connect the mitral valve to the papillary muscles along opposing walls of the left ventricle. The chordae tendineae are schematically illustrated in both the heart cross-section of FIG. 1 and the top view of the mitral valve in FIG. 2. Just before and during ventricular contraction, the papillary muscles also contract and maintain tension in the chordae tendineae, to hold the leaflets of the mitral valve in the closed position and preventing them from turning inside-out and back into the atrium, thereby also preventing backflow of the oxygenated blood into the atrium.


A general shape of the mitral valve and its leaflets as seen from the left atrium is illustrated in FIG. 2. Complications of the mitral valve can potentially cause fatal heart failure. One form of valvular heart disease is mitral valve leak, also known as mitral regurgitation, characterized by the abnormal leaking of blood from the left ventricle back into the left atrium through the mitral valve.


Mitral regurgitation is a common problem, and various options to reduce or prevent mitral regurgitation that can be more easily tolerated or handled by a body of a patient have been researched.


One repair solution for a patient exhibiting mitral regurgitation or other mitral valve leakage employs a catheter procedure, where a free edge of the anterior leaflet is attached to a free edge of the posterior leaflet. The idea for this procedure was promoted by Dr. Ottavio Alfieri, who described seeing a patient who had a congenital anomaly where the anterior leaflet edge was fused to the posterior leaflet edge, and surmised that that could potentially provide a good solution to mitral regurgitation. Dr. Alfieri performed many procedures where the mitral annulus was repaired by reduction using an annuloplasty ring to reshape the native mitral valve annulus to be smaller and/or more circular or otherwise consistent, and then controlling residual leakage by an approximation and attachment of the anterior leaflet edge to the posterior leaflet edge at a desired arrangement. Performance of many leaky mitral valves can be repaired and improved by what has become known as the Alfieri procedure, utilizing a combination of annuloplasty to reduce the diameter of the mitral annulus and leaflet edge approximation.


The Alfieri procedure has led to other variations of catheter-based procedures to attach the edges of the anterior and posterior leaflets to control mitral regurgitation. In one procedure, under echocardiographic and fluoroscopic guidance, catheters are used to introduce a clip at the mitral annulus that fastens the free edge of the anterior leaflet to the free edge of the posterior leaflet. The clip and a delivery system are typically introduced in the patient's femoral vein and passed into the right side of the heart. A transseptal puncture is then carried out in the patient's heart, and the clip is advanced into the left atrium and then the left ventricle. The edges of the leaflets are then fastened together with the clip, and the delivery system is withdrawn. In other variations of the procedure, the clip and delivery system can instead be introduced into the patient's heart from one of various other access points or positions on the patient's body.


Most patients have one clip applied during such a procedure, but if the leak is severe and/or the leaflets are highly distracted, additional clips can also be applied. The clinical results have been gratifying. Many patients have exhibited a major reduction in leakage and are symptomatically much improved when compared to before undergoing the procedure.


Another option to further reduce the mitral leakage would be to combine or to supplement one of the above annuloplasty procedures with an edge to edge leaflet plication procedure to further strengthen the bond or attachment between the native mitral leaflets.


SUMMARY

However, even after undergoing one or more of the above procedures, some patients are still left with significant mitral valve leakage. This puts an increased load on the heart, and the heart can be damaged by the long-term effects of such residual valve regurgitation.


According to embodiments of the invention, a helical or coiled anchor having turns with different radii of curvature is provided to more effectively reduce and/or reshape the native mitral valve annulus, to reduce leakage at the mitral valve. After reshaping and/or resizing the native mitral annulus, if leakage is still observed, additional measures, such as edge to edge repair or other repair procedures, can be more easily or effectively applied to the restructured mitral annulus.


In another alternative to remedy continual leakage after employing one of the above annuloplasty procedures or other similar annular reduction procedure, a prosthetic mitral valve can further be implanted into the mitral valve annulus, since an annuloplasty procedure using a coiled anchor according to embodiments of the invention will result in the formation of a stable anchor or base into or against which the prosthetic mitral valve can be docked.


According to an embodiment of the invention, an implant for reshaping a native mitral valve of a heart includes a coiled anchor having a first end, a second end, and a central axis extending between the first and second ends. The coiled anchor defines an inner space coaxial with the central axis and includes a first turn defining a central portion of the inner space having a first width, a second turn connected to the central turn at the first end of the coiled anchor, the second turn defining a portion of the inner space having a width that is smaller than the first width, and a third turn connected to the central turn at the second end of the coiled anchor, the third turn defining another portion of the inner space having a width that is smaller than the first width. The coiled anchor is implantable at the native mitral valve with at least a portion of the first turn of the coiled anchor positioned in a left ventricle of the heart and around valve leaflets of the native mitral valve.


According to another embodiment of the invention, a method for delivering an implant according to the above embodiment includes positioning the coiled anchor at a native mitral valve of a heart of a patient, such that at least a portion of the first turn of the coiled anchor is positioned in a left ventricle of the heart and around valve leaflets of the native mitral valve, positioning an expandable stent at the native mitral valve through the inner space of the coiled anchor when the stent is in a collapsed state, and expanding the stent. The stent is expandable to a width that is greater than the width of the inner space defined by at least one of the second turn or the third turn when the coiled anchor is unbiased, such that a radially outward pressure is applied by the stent on the at least one of the second turn or the third turn to increase the width of the portion of the inner space defined by the at least one of the second turn or the third turn, while the width of the portion of the inner space defined by the first turn is decreased to a width that is smaller than the first width.


According to embodiments of the invention, repair and/or replacement of a diseased mitral valve can be more effectively realized by first reshaping, resizing, and/or otherwise restructuring the native mitral annulus using a helical or coiled anchor, such that additional devices and methods can be more easily or effectively applied at the reinforced mitral position.





BRIEF DESCRIPTION OF THE DRAWINGS

Further features and advantages of the invention will become apparent from the description of embodiments using the accompanying drawings. In the drawings:



FIG. 1 shows a schematic cross-sectional view of a human heart;



FIG. 2 shows a schematic top view of the mitral valve annulus of a heart;



FIGS. 3A and 3B respectively show perspective and side views of a coil anchor for resizing or reshaping a native mitral valve annulus according to an embodiment of the invention;



FIGS. 4A-4C schematically show steps of expanding a balloon expandable stent in the coil anchor of FIGS. 3A-3B according to an embodiment of the invention;



FIGS. 5A-5C show steps of implanting a coil anchor and a balloon expandable stent at a native mitral valve according to an embodiment of the invention;



FIGS. 6A and 6B show steps of performing an edge to edge repair on a mitral valve with an implanted stent using a clip according to an embodiment of the invention;



FIGS. 7A and 7B show steps of implanting a prosthetic mitral valve at a native mitral valve annulus where an edge to edge repair was previously performed, according to an embodiment of the invention; and



FIG. 8 shows a prosthetic mitral valve fully implanted in a stent at a native mitral valve where an edge to edge repair was previously performed, according to an embodiment of the invention.





DETAILED DESCRIPTION

Disclosed herein are various implants and other devices for repairing and/or replacing the functionality of a native mitral valve, and methods of implanting such devices. By providing such devices and methods of implanting the devices, mitral valve leakage and leakage caused by similar types of valvular heart disease can be reduced, and performance of the mitral valve can be improved.


In some embodiments, a helical or coiled anchor can be used to reduce and/or reshape the annular size of a native mitral valve, in preparation for a valve repair or a further annuloplasty procedure. In other embodiments, the helical anchor can be utilized to downsize a patient's native mitral valve annulus and to make the shape of the annulus more suitable to anchor or dock a prosthetic heart valve when valve replacement is planned. In these embodiments, one of various prosthetic valves that are capable of being mounted in stents can be used in conjunction with a helical anchor that narrows and/or reshapes the native mitral valve annulus.



FIGS. 3A and 3B illustrate an embodiment of a helical or coil anchoring device according to an embodiment of the invention. The illustrated embodiment shows a helical anchor 10 that has three turns. However, in other embodiments, other helical anchors can have more or less turns depending on the particular application and the anatomy of the patient. The helical anchor 10 includes an upper first turn 12, a central second turn 14, and a lower third turn 16, and defines a space extending through the center of the helical anchor 10. The upper and lower turns 12, 16 of the anchor 10 are smaller than the central turn 14. In one embodiment, the smaller end turns 12, 16 of the helix are approximately 25 mm in diameter and the larger central turn 14 is approximately 35 mm in diameter when the anchor 10 is unbiased. However, in other embodiments, the sizes of the turns 12, 14, and 16 can be different, so long as the central turn 14 is larger than the end turns 12, 16. In embodiments with more than three turns, more than one central turn can be sized to be greater than the end turns, or there can be more than one smaller sized turn at either end of the anchor, or both. Furthermore, in some embodiments, the upper and lower turns of the anchor can have different diameters from one another.


In one embodiment, the helical anchor 10 is made from a shape memory material, such as nitinol, which will facilitate straightening of the anchor 10 for easier delivery inside a patient. In other embodiments, the anchor 10 can be made from or include one of various other biocompatible metals or of other biocompatible materials.


In addition, the core material of the helical anchor 10 can be covered by a biocompatible fabric or other biocompatible materials, to improve the stability, biocompatibility, or other functionality of the anchor 10 after it has been implanted inside the patient. Such fabrics or other covers can also serve to promote contact or friction between a stent and/or prosthetic valve with the anchor 10, to reduce the expansion of the anchor 10, and to tighten the grip of the anchor 10 on a stent or prosthetic valve that is inflated or expanded inside of it, as discussed in greater detail below.



FIG. 4A to 4C schematically show steps of inserting a balloon expandable stent into the coiled anchor 10 discussed above. FIG. 4A first shows a cross-sectional view of the anchor 10 prior to expansion of the stent or a prosthetic valve inside the anchor. Similarly as discussed above with respect to FIGS. 3A and 3B, the anchor 10 includes three turns, where the central turn 14 has a greater diameter than the end turns 12 and 16.


In FIG. 4B, a balloon 30 is inserted through the central space 18 defined by the anchor 10 and is then inflated inside the helical anchor 10 to a size that is greater than the diameter of at least one of the end turns 12, 16 of the anchor 10. In addition, the balloon 30 carries with it an expandable stent 20 that is positioned through the center of the anchor 10 before the balloon 30, and the stent 20 positioned thereon, are expanded, and the stent 20 impacts or otherwise comes into contact with the helical anchor 10.


Since the balloon is expanded to a size that is greater than the diameter of the end turns 12, 16 of the anchor 10, the expansion of the balloon 30 and the stent 20 inside the anchor 10 results in an increase in the diameters of the two end turns 12, 16. For example, where the end turns 12, 16 have an unbiased diameter of 25 mm, the balloon 30 and stent 20 can expand to up to 27 mm wide, and urge the end turns 12, 16 radially outwardly, so that the end turns are also expanded to approximately 27 mm wide. Meanwhile, as the two end turns 12, 16 are expanded, they pull on the ends of the larger central turn 14 of the anchor 10, and cause the larger central turn 14 to instead reduce in diameter. Therefore, after inflation of the balloon 30 and stent 20 inside the anchor 10, in one embodiment, the turns of the anchor 10 all end with approximately the same diameter, which in the example above is about 27 mm.


After the stent 20 has been expanded through the center of the anchor 10, the balloon 30 can be deflated and removed. FIG. 4C schematically shows a final configuration of the anchor 10 with the stent 20 expanded therethrough, after the balloon 30 has been removed. The stent 20 is held in position in the anchor 10 by the radial pressure or friction formed between the stent 20 and the turns of the anchor 10.


The stent 20 in FIG. 4C is shown with a fabric cover. The cover can cover the inside or the outside of the stent 20, or both. In other embodiments, the stent does not include a cover or other covering layer. Polyester or one of various other materials can be used for the stent cover. In other embodiments, biologic coverings, such as pericardium derived from an animal or human materials, can also be used.


Meanwhile, the stent 20 itself can be made from a stainless steel or an alloy of stainless steel, as is typically used in medical implants, or from one of various other biocompatible metals or other materials. A wide variety of stent designs can be compatible and used on conjunction with the helical anchor 10 in the method described above.


Friction between the stent 20 with at least the smaller turns of the helical anchor 10, and/or with undersides of mitral valve leaflets that are pinched between the anchor 10 and the stent 20, holds the stent 20 in position within the anchor 10. Furthermore, the larger central turn 14 can be drawn closer to the stent 20 to a degree where the central turn 14 also abuts and applies pressure against an outer surface of the stent 20. Along these same lines, when the smaller end turns 12, 16 of the anchor 10 are held more securely against the stent 20 during expansion, and movement or slippage is reduced between these surfaces, the larger central turn 14 of the anchor 10 can be pulled radially inwardly more rapidly or effectively. Therefore, surface coatings and/or other treatments or options that improve the contact or friction between the smaller turns of the anchor 10 and the stent 20 will increase the rate of reduction in diameter of the largest turn or turns of the anchor 10, leading to a tighter or more secure fixation between the parts. In one embodiment, one or more of the smaller turns of the anchor 10 has hooks, barbs, or other attachment mechanism to improve engagement with the stent 20.



FIGS. 5A to 5C show steps of implanting the coil anchor 10 and stent 20 inside a patient's heart 80, at the native mitral valve annulus 86. The native mitral valve annulus of a patient suffering from mitral regurgitation or other mitral valve leakage can be dilated, in some cases to about 35 mm. The dilated size of different diseased mitral valves can vary, and different anchors and/or stents can be utilized according to the dilated sizes or the desired sizes of the patient's native mitral valve, to treat each particular diseased valve accordingly.


In FIG. 5A, the coil anchor 10 has already been delivered inside the heart, for example, via an apical or transseptal procedure, an endovascular or transcatheter procedure, or one of various other known procedures. When the anchor 10 is in position around the native mitral valve annulus 86, two turns of the anchor 10, the lowest small turn 16 and the central larger turn 14, are located beneath the mitral valve 86, and inside the left ventricle 84. Meanwhile, the upper smaller turn 12 is located inside the left atrium 82. In other embodiments, a different combination of turns can be positioned in the left atrium 82 and the left ventricle 84, based on the application as desired by the practitioner.


In general, the larger turn 14 of the helical anchor 10 can be selected to match the diameter of the patient's enlarged mitral annulus 86, so that the anchor 10 can rest around the mitral valve annulus 86 without exerting undue pressure on the native mitral valve leaflets 88 or other portions of the mitral valve annulus 86, prior to introduction of a stent or prosthetic valve therethrough. The smaller turns 12, 16 of the anchor 10 can be selected based on the amount of shortening that is desired of the larger turn 14. In other words, the larger turn 14 can be selected based on the size of the enlarged mitral valve 86 in the diseased patient, and the size of the smaller turns 12, 16 can be selected to dictate the desired size the larger turn 14 of the anchor 10 will be reduced to, and thereby determine approximately the desired size of the treated mitral valve annulus 86 after implantation. Furthermore, the sizes and shapes of the turns 12, 14, 16 of the coiled anchor 10 can also be selected to facilitate easier placement and positioning of the anchor 10 around the native mitral valve leaflets 88 and/or the chordae tendineae (not shown) when the anchor 10 is first deployed.


After the anchor 10 is positioned at a desired location around the native mitral valve annulus 86, a balloon 30 is used to expand the anchor 10, as seen in FIG. 5B. Similarly as seen in FIG. 4B, the balloon 30 carries and delivers an expandable stent 20, which can be covered with a cover layer, as previously discussed. The deflated balloon 30 and unexpanded stent 20 are first moved in the space defined by the anchor 10, until the stent 20 is positioned at the desired location through the anchor 10.


The balloon 30 is then inflated to expand the stent 20, and this expansion causes a radially outward pressure to be applied against at least the smaller coils 12, 16 of the anchor 10. Similarly as discussed above, inflation of the balloon 30 and expansion of the stent 20 in the anchor 10 result in expansion of the lowest and highest turns 12, 16 of the anchor 10, and reduction in diameter of the larger central turn 14 of the anchor 10. The motion of the turns, and the amount of reduction in size/shape of the larger central turn 14 can be adjusted based on the amount of friction or hold between the smaller turns 12, 16 of the anchor 10 and the stent 20.


As can also be seen in FIG. 5B, since the lower turns 14, 16 are positioned outside of the native mitral valve leaflets 88, and the stent 20 is expanded inside the native mitral valve annulus 86, the valve leaflets 88 are trapped or pinched in position between the lower turns 14, 16 of the anchor 10 and the stent 20.


After the stent 20 has been expanded to its final size in the anchor 10, the balloon 30 can be removed. The stent 20 remains fixed in its expanded position within the anchor 10 after the balloon 30 is removed.


By reducing the size of the larger central turn 14 of the anchor 10 through expansion of the stent 20 therethrough, the size of the native mitral valve annulus 86 has also been reduced. This reduction in size of the valve annulus 86 is schematically shown by the arrows in FIG. 5C. For example, a diameter of a diseased or leaky mitral annulus in a patient can be 35 mm prior to treatment, but after the stent 20 is implanted and expanded in the anchor 10, the central turn 14 of the anchor 10 is reduced to about 27 mm. When the size of the larger central turn 14 of the anchor 10 is reduced, the central turn 14 urges the native valve leaflets 88 inwards, so that the size of the native mitral valve annulus 86 is also reduced from about 35 mm to about 27 mm. By using an anchor 10 and stent 20 or other type of annuloplasty ring in this manner for reducing the size of and/or for reshaping a diseased native mitral valve annulus 86, mitral regurgitation can be eliminated or greatly reduced.


Other mitral annulus variations in other patients or based on other diseases can be paired with anchors 10 and/or stents 20 having different combinations of diameters to produce optimal results for each patient and his or her needs. In each embodiment, there are one or more larger central turns that are surrounded by smaller upper and lower turns, where the larger turn or turns are used to reduce the diameter of the mitral annulus when the system is activated.


Furthermore, in the described embodiment, three complete turns are shown in the anchor 10. However, it is also possible to have an anchor where the upper and lower turns are not full turns. For example, the lower turn 16 shown in the left ventricle 84 can be a half a turn in an alternate embodiment, so that at the end of the procedure, there are less than two turns of the anchor 10 positioned in the left ventricle 84. In some embodiments, the procedure can also be performed with an anchor having only two turns, for example, one large turn and one small turn.


The embodiment in FIGS. 5A to 5C also shows an axial gap between the highest turn 12 and the central turn 14 of the anchor 10. The gap can be useful in providing a longer attachment length for the stent 20, so that there is a larger target in which to position the stent 20 during implantation. The longer length of the anchor 10 can also provide more stability to the system after implantation. In some embodiments, the longer anchor 10 can also facilitate easier initial positioning of the anchor 10 around the native mitral annulus 86. The anchor 10 in other embodiments can have larger or smaller gaps between turns, as desirable. In some embodiments, the anchor can have no gaps between turns. In embodiments with longer anchors, the longer anchors can also facilitate implantation of longer stents. The longer stents, in turn, can provide a larger target for potential valve implantation later.


In some patients, even after an annuloplasty or other mitral valve resizing or reshaping has been performed, there can still be some residual leakage. In some cases, additional measures can still be employed to further reduce leakage or otherwise improve performance of the native mitral valve.


For example, FIGS. 6A and 6B show steps of further treatment on a stented mitral valve where additional leakage reduction is desired. FIG. 6A shows the start of an edge to edge repair on the mitral valve leaflets 88 utilizing a clip 40, to eliminate or reduce any residual leak after an anchor 10 and stent 20 have already been implanted. The clip 40 is being introduced into the left ventricle 84, for example, from the left atrium 82, using one of various known delivery methods and access sites. The clip 40 can be delivered by a tool 50, and is positioned so that ends of the native mitral valve leaflets 88 can be clamped together with clip 40. The clip 40 can include one or more inner clamping surfaces 42 and one or more outer clamping surfaces 44 that are connected via a distal hinge. In the embodiment shown, the clip 40 includes two inner clamping surfaces 42 and two outer clamping surfaces 44. One or both of the clamping surfaces 42, 44 can further include teeth or other surface features to facilitate a more secure clamping of the mitral valve leaflets 88 by the clip 40. In other embodiments, other clipping or clamping devices can also be applied to the native mitral valve leaflets 88 to perform the edge to edge repair procedure.


In FIG. 6B, the clip 40 has been closed to attach the free edge of the anterior mitral valve leaflet to the free edge of the posterior mitral valve leaflet. In the example shown, the outer clamping surfaces 44 are pushed towards the inner clamping surfaces 42 to close the clip 40, and each mitral valve leaflet 88 can be pinched or clamped between a corresponding inner clamping surface 42 and a corresponding outer clamping surface 44 of the clip 40. The clip 40 is applied in this embodiment roughly in the middle of the valve orifice (for example, as can be seen in FIG. 7A). In other embodiments, the clip 40 can be applied at any of various different locations on each native mitral valve leaflet 88 based on where leakage is most severe, or where the clip 40 can reduce the most leakage. In some embodiments, more than one clip can be applied, to further reduce leakage through the native valve, as needed.


The end result, as seen in FIG. 6B, is similar to the original Alfieri type procedure, including a combination of an annuloplasty ring made up of an anchor and/or stent for reshaping the native mitral valve annulus, and an edge to edge repair performed on the native mitral valve leaflets. The sequence discussed above is shown with the annuloplasty or native valve reshaping performed first, and the edge to edge repair performed on the native valve leaflets afterwards. However, in other embodiments, the order can be reversed, where a clip is applied first (even if it was performed in conjunction with a previous procedure), and then the annuloplasty or other reshaping or resizing of the valve annulus can be performed thereafter. In procedures where an edge to edge repair is performed first, the inflatable balloon which delivers the stent afterwards can be limited by the presence of the clip, clamp, or other device used for the edge to edge repair. In these situations, a balloon having a shorter length can be used, or the stent can be positioned at a more distal position on the balloon, so that the balloon does not come into contact with the clip, to prevent damage to the clip when the balloon is inflated and the stent is expanded. It is also possible to have a balloon that is bifurcated, or Y-shaped, so that the split ends of the balloon can be positioned around the clip, where one part of the balloon passes through the valve opening on one side of the clip and the other part of the balloon passes through the valve opening on the other side of the clip. For example, referring to FIG. 7A, one end of a bifurcated balloon can pass through orifice 90 of the native valve formed by the clip 40, while the other end of the bifurcated balloon can pass through orifice 92 on the other side of the clip 40.


In some cases, the combination of the annuloplasty or native valve reshaping and the edge to edge repair is still inadequate to curb mitral regurgitation or other mitral valve leakage. The patient may still have an unacceptable leak at the mitral valve even after both of these procedures are undertaken.



FIGS. 7A, 7B, and 8 show how the anchor 10 and/or stent 20 discussed above can also serve as an ideal anchor for a stent mounted prosthetic valve. It is expensive from a regulatory approval and from a stocking standpoint to have many different valve shapes and sizes. The reduction in size of the native mitral annulus by the anchor 10 and/or the stent 20 allows for a smaller sized prosthetic stent valve to be used. Furthermore, the anchor 10 and/or the stent 20 help to reshape the native mitral annulus to be more circular, so that more conventional valves with circular or cylindrical outer profiles that are already on the market can be used at the mitral position. In addition, the heart may be able to function more efficiently or effectively with a smaller annulus diameter at the mitral position, since the mitral valve will not be stretched open as widely and can contract more completely. Therefore, a mitral valve anchor or stent that serves to downsize a native mitral valve annulus to a more uniform shape and/or size can allow for a lower number of valves or variations of valves to be produced, saving costs and simplify the manufacturing and implantation procedures.



FIG. 7A shows a top view of a mitral annulus that has already undergone a reshaping using an anchor 10 and/or a stent (not shown in FIG. 7A), as well as an edge to edge procedure using a clip 40 to clip distal ends of the native mitral valve leaflets 88. The edge to edge repair has formed two orifices 90, 92, at the mitral position on either side of the clip 40, respectively. In some patients, the prior procedures may not prove to be sufficient to curb or reduce the mitral leakage through the mitral valve illustrated in FIG. 7A. Therefore, a balloon that carries a stent mounted prosthetic valve 60 can further be positioned across the mitral valve through one of the mitral orifices 90 or 92. The prosthetic valve 60 that is deployed and implanted can be one of various different known valves with a size and shape suitable for fitting in the anchor 10, for example, the Edwards Lifesciences Sapien XT™ valve.


In FIG. 7B, the prosthetic valve 60 is expanded, for example, via inflation of a balloon delivery system. The expansion of the prosthetic valve 60 places a large radial force or load on the native mitral leaflets 88 that were previously clipped together with the clip 40 during the earlier edge to edge repair. As can be seen in FIG. 7B, the expansion of the prosthetic valve 60 begins displacing the clip 40 and stretching out the native mitral leaflets 88, and eventually, at least one of the leaflets 88 tears away from the clip 40, slips out of the clip 40, or otherwise detaches from the clip 40.


To encourage or promote cutting or tearing of the native mitral valve leaflets 88, the above valve expansion procedure can be preceded by inflation of a separate balloon at the mitral position that cuts the native mitral valve leaflets 88. Similar cutting balloons have been used, for example, to cut away plaques in arteries. Another option can be to cut a defect in at least one of the native mitral valve leaflets 88, and then to advance the stent valve inside or adjacent to the pre-cut portion of the leaflet 88. In other embodiments, the stent in which the prosthetic mitral valve is mounted can have its own cutting features, for cutting surrounding portions of the native mitral leaflets 88, to further facilitate expansion of the prosthetic valve 60.


In some embodiments, the prosthetic valve 60 can be implanted with the clip 40 from the edge to edge repair remaining intact. In such cases, it would be necessary to ensure that an adequately sized orifice is formed in which the prosthetic valve 60 can be positioned, to allow adequate flow into the left ventricle. If there is an obstruction to flow, or if the orifice is not sufficiently sized, the clip 40 can still be cut from one edge of the mitral valve leaflets 88 thereafter, to form a more suitable orifice or opening for the prosthetic valve 60.


In some cases, it is possible that the clip 40 detaches from both of the native mitral leaflet edges 88. This would be highly unusual since it would mean that the retention of the clip 40 on both leaflets was virtually identical. However, in such instances, the clip 40 can be easily retrieved and removed from the patient.


Generally, after one of the native mitral leaflets 88 is ripped or torn from the clip 40, the prosthetic valve is free to expand until it abuts against the anchor 10 and/or the stent 20. FIG. 8 shows the prosthetic valve 60 after it has been fully expanded. The valve 60 sits securely inside the prior annuloplasty apparatus including the anchor 10 and the stent 20. The pre-positioned anchor 10 and stent 20 provide an excellent target for insertion and expansion of the prosthetic valve 60. The annuloplasty apparatus can be clearly visible on fluoroscopy.


As previously discussed, one of the native mitral leaflets 88 has been torn or ripped or otherwise detached from the clip 40 at the tear 94, and the functionality of the native mitral leaflets 88 has been replaced by the prosthetic valve 60. The clip 40, which has detached from one of the native mitral leaflets 88, is shown inside the left ventricle 84, and should not affect the functionality of the prosthetic valve 60.


In other embodiments, various different features from the different embodiments discussed above can also be combined or modified, based on the needs of each individual patient. For example, the annuloplasty or mitral annulus reshaping procedure does not need to be performed in conjunction with an edge to edge procedure. Instead, the annuloplasty or mitral reshaping can be a standalone procedure. In addition, if the annuloplasty procedure is not adequate to remedy a diseased heart, and the leakage seems too severe to be solved by implantation of one or more clips via an edge to edge repair, it is also possible to proceed directly from annuloplasty or mitral reshaping to implantation of a prosthetic mitral valve inside the anchor and/or the stent used for the annuloplasty or mitral reshaping.


For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatus, and systems should not be construed as being limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatus, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.


Although the operations of some of the disclosed embodiments are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language set forth below. For example, operations described sequentially can in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. Additionally, the description sometimes uses terms like “provide” or “achieve” to describe the disclosed methods. These terms are high-level abstractions of the actual operations that are performed. The actual operations that correspond to these terms can vary depending on the particular implementation and are readily discernible by one of ordinary skill in the art.


In view of the many possible embodiments to which the principles of the disclosure can be applied, it should be recognized that the illustrated embodiments are only preferred examples and should not be taken as limiting the scope of the disclosure. Rather, the scope of the disclosure is defined by the following claims.

Claims
  • 1. An implant for a native mitral valve of a heart, the implant comprising a coiled anchor that comprises: a plurality of ventricular turns;one or more atrial turns connected to the plurality of ventricular turns;wherein the coiled anchor is configured to be implanted at the native mitral valve with the plurality of ventricular turns positioned in a left ventricle of the heart and around valve leaflets of the native mitral valve; andwherein the plurality of ventricular turns are configured such that when a radially outward pressure is applied to at least one of the plurality of ventricular turns, the coiled anchor is biased such that a first diameter of a first turn of the plurality of ventricular turns is expanded and a second diameter of a second turn of the plurality of ventricular turns is reduced such that the first diameter and the second diameter are the same.
  • 2. The implant according to claim 1, further comprising a prosthetic valve having an expandable frame that houses a plurality of leaflets for controlling blood flow therethrough, wherein the expandable frame is configured to be expanded in an inner space defined by the plurality of ventricular turns of the coiled anchor.
  • 3. The implant according to claim 2, wherein the expandable frame is expandable to a diameter that is greater than the first diameter when the coiled anchor is unbiased.
  • 4. The implant according to claim 2, wherein the coiled anchor is configured for positioning such that the one or more atrial turns are spaced apart from an outer surface of the expandable frame when the expandable frame is expanded.
  • 5. The implant according to claim 4, wherein the coiled anchor is configured for positioning such that the one or more atrial turns do not engage an inner wall of a left atrium when the expandable frame is expanded.
  • 6. The implant according to claim 2, wherein at least one of the plurality of ventricular turns is configured to compress the valve leaflets of the native mitral valve against an outer surface of the expandable frame of the prosthetic valve when the expandable frame is expanded, while the one or more atrial turns are configured to be spaced apart from the outer surface of the expandable frame.
  • 7. The implant according to claim 2, wherein at least one of the one or more atrial turns and the plurality of ventricular turns of the coiled anchor is configured to attach to an outer surface of the expandable frame.
  • 8. The implant according to claim 1, wherein the one or more atrial turns is a single atrial turn.
  • 9. The implant according to claim 8, wherein an axial distance between a centerline of a first cross-section the first turn of the plurality of ventricular turns and a centerline of a second cross-section of the second turn of the plurality of ventricular turns is less than a second axial distance between the centerline of the first cross-section of the first turn and a third centerline of a cross-section of the single atrial turn.
  • 10. A system for repairing a native mitral valve of a heart, comprising: a coiled anchor, and a prosthetic valve;wherein the coiled anchor comprises:a plurality of ventricular turns;one or more atrial turns connected to the plurality of ventricular turns;wherein the prosthetic valve comprises: an expandable frame configured to be expanded in an inner space defined by the plurality of ventricular turns of the coiled anchor;a plurality of leaflets disposed within the expandable frame for controlling bloodflow through the prosthetic valve;wherein the coiled anchor is configured to be implanted at the native mitral valve with the plurality of ventricular turns positioned in a left ventricle of the heart and around valve leaflets of the native mitral valve; andwherein the plurality of ventricular turns are configured such that when a radially outward pressure is applied to at least one of the plurality of ventricular turns, the coiled anchor is biased such that a first diameter of a first of the plurality of ventricular turns is expanded and a second diameter of a second of the plurality of ventricular turns is reduced such that the first diameter and the second diameter are the same.
  • 11. The system according to claim 10, wherein the expandable frame is expandable to a maximum expanded diameter that is greater than the first diameter.
  • 12. The system according to claim 10, wherein at least one of the one or more atrial turns and the plurality of ventricular turns of the coiled anchor is configured to attach to an outer surface of the expandable frame.
  • 13. The system according to claim 10, wherein the coiled anchor is configured for positioning such that the one or more atrial turns are spaced apart from an outer surface of the expandable frame when the expandable frame is expanded.
  • 14. The system according to claim 13, wherein the one or more atrial turns do not engage an inner wall of a left atrium when the expandable frame is expanded.
  • 15. The system according to claim 10, wherein at least one of the plurality of ventricular turns is configured to compress the valve leaflets of the native mitral valve against an outer surface of the expandable frame of the prosthetic valve when the expandable frame is expanded.
  • 16. The system according to claim 15, wherein the one or more atrial turns are configured to be spaced apart from the outer surface of the expandable frame.
  • 17. The system according to claim 10, wherein the expandable frame is covered by a cover layer.
  • 18. The system according to claim 10, wherein the one or more atrial turns is a single atrial turn and wherein an axial distance between a centerline of a first cross-section of the first turn of the plurality of ventricular turns and a centerline of a second cross-section of the second turn of the plurality of ventricular turns is less than a second axial distance between the centerline of the first cross-section of the first turn and a centerline of a third cross-section of the single atrial turn.
  • 19. The system according to claim 10, further comprising a clip configured to hold respective ends of the valve leaflets of the native mitral valve together.
Parent Case Info

This application is a continuation of U.S. patent application Ser. No. 16/877,366, filed May 18, 2020, which is a continuation of U.S. patent application Ser. No. 16/029,355, filed Jul. 6, 2018, which is a divisional of U.S. patent application Ser. No. 14/850,822, filed Sep. 10, 2015, which claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 62/049,432, filed Sep. 12, 2014 and also claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 62/073,088, filed Oct. 31, 2014, the contents of all of the above-identified patent applications are hereby incorporated by reference in their entirety.

US Referenced Citations (496)
Number Name Date Kind
30912 Hancock Dec 1860 A
3409013 Berry Nov 1968 A
3548417 Kisher Dec 1970 A
3564617 Sauvage et al. Feb 1971 A
3587115 Shiley Jun 1971 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3755823 Hancock Sep 1973 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4106129 Carpentier et al. Aug 1978 A
4222126 Boretos et al. Sep 1980 A
4265694 Boretos et al. May 1981 A
4297749 Davis et al. Nov 1981 A
4339831 Johnson Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4373216 Klawitter Feb 1983 A
4406022 Roy Sep 1983 A
4441216 Ionescu et al. Apr 1984 A
4470157 Love Sep 1984 A
4490859 Black et al. Jan 1985 A
4512338 Balko et al. Apr 1985 A
4535483 Klawitter et al. Aug 1985 A
4574803 Storz Mar 1986 A
4592340 Boyles Jun 1986 A
4605407 Black et al. Aug 1986 A
4612011 Kautzky Sep 1986 A
4643732 Pietsch et al. Feb 1987 A
4655771 Wallsten Apr 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
4733665 Palmaz Mar 1988 A
4759758 Gabbay Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4787901 Baykut Nov 1988 A
4790843 Carpentier et al. Dec 1988 A
4796629 Grayzel Jan 1989 A
4820299 Philippe et al. Apr 1989 A
4829990 Thuroff et al. May 1989 A
4851001 Taheri Jul 1989 A
4856516 Hillstead Aug 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4922905 Strecker May 1990 A
4966604 Reiss Oct 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
5007896 Shiber Apr 1991 A
5026366 Leckrone Jun 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5080668 Bolz et al. Jan 1992 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5163953 Vince Nov 1992 A
5167628 Boyles Dec 1992 A
5192297 Hull Mar 1993 A
5266073 Wall Nov 1993 A
5282847 Trescony et al. Feb 1994 A
5295958 Shturman Mar 1994 A
5332402 Teitelbaum Jul 1994 A
5360444 Kusuhara Nov 1994 A
5370685 Stevens Dec 1994 A
5397351 Pavcnik et al. Mar 1995 A
5403305 Sauter et al. Apr 1995 A
5411055 Kane May 1995 A
5411552 Andersen et al. May 1995 A
5443446 Shturman Aug 1995 A
5443500 Sigwart Aug 1995 A
5480424 Cox Jan 1996 A
5500014 Quijano et al. Mar 1996 A
5545209 Roberts et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5549665 Vesely et al. Aug 1996 A
5554185 Block et al. Sep 1996 A
5558644 Boyd et al. Sep 1996 A
5571175 Vanney et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5591185 Kilmer et al. Jan 1997 A
5591195 Taheri et al. Jan 1997 A
5607464 Trescony et al. Mar 1997 A
5609626 Quijano et al. Mar 1997 A
5628792 Lentell May 1997 A
5639274 Fischell et al. Jun 1997 A
5665115 Cragg Sep 1997 A
5716417 Girard et al. Feb 1998 A
5728068 Leone et al. Mar 1998 A
5749890 Shaknovich May 1998 A
5756476 Epstein et al. May 1998 A
5769812 Stevens et al. Jun 1998 A
5800508 Goicoechea et al. Sep 1998 A
5840081 Andersen et al. Nov 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855602 Angell Jan 1999 A
5925063 Khosravi Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
6027525 Suh et al. Feb 2000 A
6120534 Ruiz Sep 2000 A
6132473 Williams et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6174327 Mertens et al. Jan 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6217585 Houser et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6231602 Carpentier et al. May 2001 B1
6235042 Katzman May 2001 B1
6245102 Jayaraman Jun 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6306141 Jervis Oct 2001 B1
6338740 Carpentier Jan 2002 B1
6350277 Kocur Feb 2002 B1
6352547 Brown et al. Mar 2002 B1
6406492 Lytle Jun 2002 B1
6409758 Stobie et al. Jun 2002 B2
6419696 Ortiz et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6432134 Anson et al. Aug 2002 B1
6440764 Focht et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468660 Ogle et al. Oct 2002 B2
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6527979 Constantz Mar 2003 B2
6569196 Vesely May 2003 B1
6582462 Andersen et al. Jun 2003 B1
6605112 Moll et al. Aug 2003 B1
6625578 Spaur et al. Sep 2003 B2
6652578 Bailey et al. Nov 2003 B2
6676698 McGuckin, Jr. et al. Jan 2004 B2
6689123 Pinchasik Feb 2004 B2
6716244 Klaco Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6730121 Ortiz et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6767362 Schreck Jul 2004 B2
6769161 Brown et al. Aug 2004 B2
6783542 Eidenschink Aug 2004 B2
6797002 Spence et al. Sep 2004 B2
6830584 Seguin Dec 2004 B1
6878162 Bales et al. Apr 2005 B2
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6936067 Buchanan Aug 2005 B2
6971998 Rosenman et al. Dec 2005 B2
7018406 Seguin et al. Mar 2006 B2
7018408 Bailey et al. Mar 2006 B2
7037334 Hlavka et al. May 2006 B1
7077861 Spence Jul 2006 B2
7096554 Austin et al. Aug 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7166126 Spence et al. Jan 2007 B2
7166127 Spence et al. Jan 2007 B2
7225518 Eidenschink et al. Jun 2007 B2
7276078 Spenser et al. Oct 2007 B2
7276084 Yang et al. Oct 2007 B2
7316710 Cheng et al. Jan 2008 B1
7318278 Zhang et al. Jan 2008 B2
7374571 Pease et al. May 2008 B2
7393360 Spenser et al. Jul 2008 B2
7404824 Webler et al. Jul 2008 B1
7431726 Spence et al. Oct 2008 B2
7445632 McGuckin, Jr. et al. Nov 2008 B2
7462191 Spenser et al. Dec 2008 B2
7510575 Spenser et al. Mar 2009 B2
7527646 Rahdert et al. May 2009 B2
7563280 Anderson et al. Jul 2009 B2
7585321 Cribier Sep 2009 B2
7618446 Andersen et al. Nov 2009 B2
7618447 Case et al. Nov 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7637946 Solem et al. Dec 2009 B2
7655034 Mitchell et al. Feb 2010 B2
7708775 Rowe et al. May 2010 B2
7737060 Strickler et al. Jun 2010 B2
7758639 Mathis Jul 2010 B2
7780726 Seguin Aug 2010 B2
7785366 Maurer et al. Aug 2010 B2
7942927 Kaye et al. May 2011 B2
7951195 Antonsson et al. May 2011 B2
7955385 Crittenden Jun 2011 B2
7959665 Pienknagura Jun 2011 B2
7959672 Salahieh et al. Jun 2011 B2
7993394 Hariton et al. Aug 2011 B2
8016882 Macoviak et al. Sep 2011 B2
8029556 Rowe Oct 2011 B2
8052750 Tuval et al. Nov 2011 B2
8075611 Millwee et al. Dec 2011 B2
8092520 Quadri Jan 2012 B2
8128686 Paul, Jr. et al. Mar 2012 B2
8128691 Keranen Mar 2012 B2
8142492 Forster et al. Mar 2012 B2
8167932 Bourang et al. May 2012 B2
8236049 Rowe et al. Aug 2012 B2
8291570 Eidenschink et al. Oct 2012 B2
8323335 Rowe et al. Dec 2012 B2
8348998 Pintor et al. Jan 2013 B2
8377115 Thompson Feb 2013 B2
8398708 Meiri et al. Mar 2013 B2
8449599 Chau et al. May 2013 B2
8449605 Lichtenstein et al. May 2013 B2
8449606 Eliasen et al. May 2013 B2
8454685 Hariton et al. Jun 2013 B2
8652203 Quadri et al. Feb 2014 B2
8657872 Seguin Feb 2014 B2
8663322 Keranen Mar 2014 B2
8672998 Lichtenstein et al. Mar 2014 B2
8685086 Navia et al. Apr 2014 B2
8734507 Keranen May 2014 B2
8747463 Fogarty et al. Jun 2014 B2
8795352 O'Beirne et al. Aug 2014 B2
8801776 House et al. Aug 2014 B2
8840664 Karapetian et al. Sep 2014 B2
8986373 Chau et al. Mar 2015 B2
9078747 Conklin Jul 2015 B2
9078781 Ryan et al. Jul 2015 B2
9095434 Rowe Aug 2015 B2
9119718 Keranen Sep 2015 B2
9192471 Bolling Nov 2015 B2
9237886 Seguin et al. Jan 2016 B2
9314335 Konno Apr 2016 B2
9326853 Olson et al. May 2016 B2
9364326 Yaron Jun 2016 B2
9463268 Spence Oct 2016 B2
9474599 Keranen Oct 2016 B2
9526572 Kunis Dec 2016 B2
9597205 Tuval Mar 2017 B2
9622863 Karapetian et al. Apr 2017 B2
9867702 Keränen et al. Jan 2018 B2
10016272 Spence et al. Jul 2018 B2
10016276 Brunnett et al. Jul 2018 B2
10034749 Spence et al. Jul 2018 B2
10039637 Maimon et al. Aug 2018 B2
10052198 Chau et al. Aug 2018 B2
10195028 Hosmer et al. Feb 2019 B2
10195033 Tuval et al. Feb 2019 B2
10226339 Spence et al. Mar 2019 B2
10357361 Rafi et al. Jul 2019 B2
10463479 Manash et al. Nov 2019 B2
10828150 Tamir Nov 2020 B2
11020225 Keränen et al. Jun 2021 B2
11039924 Yaron Jun 2021 B2
11065111 Manash et al. Jul 2021 B2
11141273 Dakin et al. Oct 2021 B2
11185406 Haivatov et al. Nov 2021 B2
11364114 Gorman, III et al. Jun 2022 B2
11382748 Keränen et al. Jul 2022 B2
11471282 Argento et al. Oct 2022 B2
11547563 Keränen et al. Jan 2023 B2
11654025 O'Carroll et al. May 2023 B2
11666441 McDaniel et al. Jun 2023 B2
20010021872 Bailey et al. Sep 2001 A1
20020026094 Roth Feb 2002 A1
20020032481 Gabbay Mar 2002 A1
20020045936 Moe Apr 2002 A1
20020107535 Wei et al. Aug 2002 A1
20020138135 Duerig et al. Sep 2002 A1
20020143390 Ishii Oct 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020173842 Buchanan Nov 2002 A1
20030014105 Cao Jan 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030100939 Yodfat et al. May 2003 A1
20030158597 Quiachon et al. Aug 2003 A1
20030167089 Lane Sep 2003 A1
20030212454 Scott et al. Nov 2003 A1
20030225420 Wardle Dec 2003 A1
20040024452 Kruse et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040078074 Anderson et al. Apr 2004 A1
20040111006 Alferness et al. Jun 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040260389 Case et al. Dec 2004 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050075725 Rowe Apr 2005 A1
20050075728 Nguyen et al. Apr 2005 A1
20050096736 Osse et al. May 2005 A1
20050096738 Cali et al. May 2005 A1
20050119682 Nguyen et al. Jun 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050182486 Gabbay Aug 2005 A1
20050188525 Weber et al. Sep 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20060004469 Sokel Jan 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060108090 Ederer et al. May 2006 A1
20060149350 Patel et al. Jul 2006 A1
20060183383 Asmus et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060229719 Marquez et al. Oct 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271172 Tehrani Nov 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20070005131 Taylor Jan 2007 A1
20070010876 Salahieh et al. Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070112422 Dehdashtian May 2007 A1
20070162102 Ryan et al. Jul 2007 A1
20070185572 Solem et al. Aug 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070208550 Cao et al. Sep 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070232898 Huynh et al. Oct 2007 A1
20070233228 Eberhardt et al. Oct 2007 A1
20070244553 Rafiee et al. Oct 2007 A1
20070260305 Drews et al. Nov 2007 A1
20070265700 Eliasen et al. Nov 2007 A1
20070293808 Williams et al. Dec 2007 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080021546 Patz et al. Jan 2008 A1
20080033542 Antonsson et al. Feb 2008 A1
20080077235 Kirson Mar 2008 A1
20080114442 Mitchell et al. May 2008 A1
20080125853 Bailey et al. May 2008 A1
20080140190 Macoviak et al. Jun 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080183271 Frawley et al. Jul 2008 A1
20080208327 Rowe Aug 2008 A1
20080208330 Keranen Aug 2008 A1
20080228265 Spence et al. Sep 2008 A1
20080243245 Thambar et al. Oct 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080275503 Spence et al. Nov 2008 A1
20080275537 Limon Nov 2008 A1
20080294248 Yang et al. Nov 2008 A1
20090118826 Khaghani May 2009 A1
20090125118 Gong May 2009 A1
20090157175 Benichou Jun 2009 A1
20090177278 Spence Jul 2009 A1
20090192601 Rafiee et al. Jul 2009 A1
20090234318 Loulmet et al. Sep 2009 A1
20090259307 Gross et al. Oct 2009 A1
20090276038 Tremulis et al. Nov 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090287296 Manasse Nov 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20090299452 Eidenschink et al. Dec 2009 A1
20090299471 Keranen Dec 2009 A1
20090319037 Rowe et al. Dec 2009 A1
20100004735 Yang et al. Jan 2010 A1
20100036484 Hariton et al. Feb 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100076549 Keidar et al. Mar 2010 A1
20100082094 Quadri et al. Apr 2010 A1
20100145440 Keranen Jun 2010 A1
20100152839 Shandas et al. Jun 2010 A1
20100161047 Cabiri Jun 2010 A1
20100168844 Toomes et al. Jul 2010 A1
20100185277 Braido et al. Jul 2010 A1
20100198347 Zakay et al. Aug 2010 A1
20100204781 Alkhatib Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100312333 Navia et al. Dec 2010 A1
20100318183 Keranen Dec 2010 A1
20100318184 Spence Dec 2010 A1
20100331971 Keranen et al. Dec 2010 A1
20100331973 Keranen Dec 2010 A1
20110015729 Jimenez et al. Jan 2011 A1
20110022157 Essinger et al. Jan 2011 A1
20110066224 White Mar 2011 A1
20110098802 Braido et al. Apr 2011 A1
20110106247 Miller et al. May 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110178597 Navia et al. Jul 2011 A9
20110208298 Tuval et al. Aug 2011 A1
20110218619 Benichou et al. Sep 2011 A1
20110218621 Antonsson et al. Sep 2011 A1
20110224785 Hacohen Sep 2011 A1
20110245911 Quill et al. Oct 2011 A1
20110288634 Tuval et al. Nov 2011 A1
20110295361 Claiborne, III et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20110319990 Macoviak et al. Dec 2011 A1
20110319991 Hariton et al. Dec 2011 A1
20120016464 Seguin Jan 2012 A1
20120053680 Bolling et al. Mar 2012 A1
20120059458 Buchbinder et al. Mar 2012 A1
20120089223 Nguyen et al. Apr 2012 A1
20120101571 Thambar et al. Apr 2012 A1
20120123529 Levi et al. May 2012 A1
20120150287 Forster et al. Jun 2012 A1
20120259409 Nguyen et al. Oct 2012 A1
20120283820 Tseng et al. Nov 2012 A1
20120310328 Olson et al. Dec 2012 A1
20120316643 Keranen Dec 2012 A1
20130006352 Yaron Jan 2013 A1
20130023985 Khairkhahan et al. Jan 2013 A1
20130046373 Cartledge et al. Feb 2013 A1
20130150956 Yohanan et al. Jun 2013 A1
20130166017 Cartledge et al. Jun 2013 A1
20130190857 Mitra et al. Jul 2013 A1
20130190865 Anderson Jul 2013 A1
20130204311 Kunis Aug 2013 A1
20130274873 Delaloye et al. Oct 2013 A1
20130310917 Richter et al. Nov 2013 A1
20130310926 Hariton Nov 2013 A1
20130310928 Morriss et al. Nov 2013 A1
20130317598 Rowe et al. Nov 2013 A1
20130331929 Mitra et al. Dec 2013 A1
20140074229 Figulla et al. Mar 2014 A1
20140074299 Endou et al. Mar 2014 A1
20140081394 Keranen et al. Mar 2014 A1
20140163669 Ben-Zvi et al. Jun 2014 A1
20140172070 Seguin Jun 2014 A1
20140194981 Menk et al. Jul 2014 A1
20140200661 Pintor et al. Jul 2014 A1
20140209238 Bonyuet et al. Jul 2014 A1
20140222136 Geist et al. Aug 2014 A1
20140236287 Clague et al. Aug 2014 A1
20140257466 Board et al. Sep 2014 A1
20140277417 Schraut et al. Sep 2014 A1
20140277419 Garde et al. Sep 2014 A1
20140277424 Oslund Sep 2014 A1
20140277563 White Sep 2014 A1
20140296962 Cartledge et al. Oct 2014 A1
20140330372 Weston et al. Nov 2014 A1
20140343670 Bakis et al. Nov 2014 A1
20140343671 Yohanan et al. Nov 2014 A1
20140350667 Braido et al. Nov 2014 A1
20140358222 Gorman, III et al. Dec 2014 A1
20140379074 Spence et al. Dec 2014 A1
20150025623 Granada et al. Jan 2015 A1
20150073545 Braido Mar 2015 A1
20150073546 Braido Mar 2015 A1
20150135506 White May 2015 A1
20150157455 Hoang et al. Jun 2015 A1
20150190227 Johnson et al. Jul 2015 A1
20150230921 Chau et al. Aug 2015 A1
20150245910 Righini et al. Sep 2015 A1
20150282931 Brunnett et al. Oct 2015 A1
20150335428 Keranen Nov 2015 A1
20150335430 Loulmet et al. Nov 2015 A1
20150374493 Yaron et al. Dec 2015 A1
20160015514 Lashinski et al. Jan 2016 A1
20160074165 Spence et al. Mar 2016 A1
20160095705 Keranen et al. Apr 2016 A1
20160143732 Glimsdale May 2016 A1
20160184095 Spence et al. Jun 2016 A1
20160199177 Spence et al. Jul 2016 A1
20160256276 Yaron Sep 2016 A1
20160346080 Righini et al. Dec 2016 A1
20160374802 Levi et al. Dec 2016 A1
20170007399 Keranen Jan 2017 A1
20170007402 Zerkowski et al. Jan 2017 A1
20170014229 Nguyen-Thien-Nhon et al. Jan 2017 A1
20170217385 Rinkleff et al. Aug 2017 A1
20170266005 McGuckin, Jr. Sep 2017 A1
20170273789 Yaron et al. Sep 2017 A1
20170281337 Campbell Oct 2017 A1
20170360426 Hacohen et al. Dec 2017 A1
20180000580 Wallace et al. Jan 2018 A1
20180028310 Gurovich et al. Feb 2018 A1
20180085217 Lashinski et al. Mar 2018 A1
20180153689 Maimon et al. Jun 2018 A1
20180206074 Tanasa et al. Jul 2018 A1
20180289481 Dolan Oct 2018 A1
20180303606 Rothstein et al. Oct 2018 A1
20180318073 Tseng et al. Nov 2018 A1
20180318080 Quill et al. Nov 2018 A1
20180325665 Gurovich et al. Nov 2018 A1
20180344456 Barash et al. Dec 2018 A1
20190159894 Levi et al. May 2019 A1
20190192288 Levi et al. Jun 2019 A1
20190192289 Levi et al. Jun 2019 A1
20200054453 Zerkowski et al. Feb 2020 A1
20200360143 O'Carroll et al. Nov 2020 A1
20210212826 Zerkowski et al. Jul 2021 A1
20210361426 Hacohen Nov 2021 A1
20230086853 Zerkowski et al. Mar 2023 A1
Foreign Referenced Citations (93)
Number Date Country
1684644 Oct 2005 CN
1714766 Jan 2006 CN
101588771 Nov 2009 CN
0144167 Sep 1903 DE
2246526 Mar 1973 DE
19532846 Mar 1997 DE
19546692 Jun 1997 DE
19857887 Jul 2000 DE
19907646 Aug 2000 DE
10049812 Apr 2002 DE
10049813 Apr 2002 DE
10049814 Apr 2002 DE
10049815 Apr 2002 DE
0103546 Mar 1984 EP
0592410 Oct 1995 EP
0850607 Jul 1998 EP
1057460 Dec 2000 EP
1088529 Apr 2001 EP
1570809 Sep 2005 EP
1296618 Jan 2008 EP
2072027 Jun 2009 EP
1827314 Dec 2010 EP
3395296 Dec 2019 EP
2747708 Jan 2022 EP
2788217 Jul 2000 FR
2815844 May 2002 FR
2056023 Mar 1981 GB
1271508 Nov 1986 SU
9117720 Nov 1991 WO
9217118 Oct 1992 WO
9301768 Feb 1993 WO
9724080 Jul 1997 WO
9829057 Jul 1998 WO
9930646 Jun 1999 WO
9933414 Jul 1999 WO
9940964 Aug 1999 WO
9947075 Sep 1999 WO
0018333 Apr 2000 WO
0041652 Jul 2000 WO
0047139 Aug 2000 WO
0135878 May 2001 WO
0149213 Jul 2001 WO
0154624 Aug 2001 WO
0154625 Aug 2001 WO
0162189 Aug 2001 WO
0164137 Sep 2001 WO
0176510 Oct 2001 WO
0222054 Mar 2002 WO
0236048 May 2002 WO
0241789 May 2002 WO
0243620 Jun 2002 WO
0247575 Jun 2002 WO
0249540 Jun 2002 WO
03047468 Jun 2003 WO
2005034812 Apr 2005 WO
2005055883 Jun 2005 WO
2005084595 Sep 2005 WO
2006011127 Feb 2006 WO
2006014233 Feb 2006 WO
2006032051 Mar 2006 WO
2006034008 Mar 2006 WO
2006111391 Oct 2006 WO
2006127089 Nov 2006 WO
2006138173 Dec 2006 WO
2005102015 Apr 2007 WO
2007047488 Apr 2007 WO
2007067942 Jun 2007 WO
2007097983 Aug 2007 WO
2008005405 Jan 2008 WO
2008015257 Feb 2008 WO
2008035337 Mar 2008 WO
2008091515 Jul 2008 WO
2008147964 Dec 2008 WO
2008150529 Dec 2008 WO
2009033469 Mar 2009 WO
2009042196 Apr 2009 WO
2009053497 Apr 2009 WO
2009061389 May 2009 WO
2009094188 Jul 2009 WO
2009116041 Sep 2009 WO
2009134701 Nov 2009 WO
2009149462 Dec 2009 WO
2010011699 Jan 2010 WO
2010057262 May 2010 WO
2010121076 Oct 2010 WO
2012063228 May 2012 WO
2013106585 Jul 2013 WO
2013110722 Aug 2013 WO
2013114214 Aug 2013 WO
2015023579 Feb 2015 WO
2015085218 Jun 2015 WO
2015198125 Dec 2015 WO
2017103833 Jun 2017 WO
Non-Patent Literature Citations (29)
Entry
Al-Khaja, et al. “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, vol. 3. pp. 305-311. 1989.
Bailey, S. “Percutaneous Expandable Prosthetic Valves,” Textbook of Interventional Cardiology vol. 2, 2nd Ed. pp. 1268-1276. 1994.
Bonhoeffer et at., “Percutaneous Replacement of Pulmonary valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Early Report, The Lancet, vol. 356, Oct. 21, 2000.
Casselman et al., “Reducing Operative Morality in Valvular Reoperations: The “valve in ring” Procedure,” Brief Technique Reports, The Journal of Thoracic and Cardiovascular Surgery, vol. 141, No. 5. May 2011.
Cheung et al, Live Case Transmissions, Nyha III CHF, Case Summary, Sep. 23, 2010, St. Paul's Hospital/University of British Columbia.
Cheung et al,“Transapical Transcatheter Mitral Valve-in-Valve Implantation in a Human,” The Society of Thoracic Surgeons, 2009.
Descoutures et al., “Transcatheter Valve-in-Ring Implantation After Failure of Surgical Mitral Repair,” European Journal of Cardio-Thoracic Surgery 44, e8-e15, 2013.
H.R. Andersen “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009.
H.R. Andersen, et al. “Transluminal Implantation of Artificial Heart Valve. Description of a New Expandable Aortic Valve and Initial Results with implantation by Catheter Technique in Closed Chest Pig,” European Heart Journal, No. 13. pp. 704-708. 1992.
Himbert et al., “Transseptal Implantation of a Transcatheter Heart Valve in a Mitral Annuloplasty Ring to Treat Mitral Repair Failure,” Circulation Cardiovascular Interventions, American Heart Association, 2011.
Himbert, Dominique, “Transvenous Mitral Valve Repair Replacement After Failure of Surgical Ring Annuloplasty,” Research Correspondence, Journal of the American College of Cardiology, 2012.
International Search Report from corresponding PCT case No. PCT/IB2015/000901 dated Feb. 15, 2015.
Kempfert et al., “Minimally invasive off-pump valve-in-a-ring implantation: the atrial transcatheter approach for re-operative mitral valve replacement after failed repair,” European Journal of Cardiothoracic Surgery, 2009, 35:965-969.
Ma et al., “Double-Crowned Valved Stents for Off-Pump Mitral Valve Replacement,” European Journal of Cardio-Thoracic Surgery, 28, 194-199, 2005.
Patrick W. Serruys, Nicolo Piazza, Alain Cribier, John Webb, Jean-Claude Laborde, Peter de Jaegere, “Transcatheter Aortic Valve Implantation: Tips and Tricks to Avoid Failure”; we file the table of contents and pp. 18 to 39 (Chapter 2) and pp. 102-114 (Chapter 8); the publication date according to the “Library of Congress Cataloging-in-Publication Data” is Nov. 24, 2009.
Pavcnik, et al. “Development and initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology, vol. 183, No. 1. pp. 151-154. 1992.
Ross, “Aortic Valve Surgery,” At a meeting of the Council on Aug. 4, 1966. pp. 192-197.
Sabbah, et al. “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Journal of Cardiac Surgery, vol. 4, No. 4. pp. 302-309. 1989.
Shuto et al., “Percutaneous Transvenous Melody Valve-in-Ring Procedure for Mitral Valve Replacement,” J Am Coll Cardiol, 58(24): 2475-2480, 2011.
Uchida, “Modifications of Gianturco Expandable Wire Stents,” American Journal of Roentgenology, vol. 150. pp. 1185-1187. 1986.
Walther et al., “Human Minimally Invasive Off-Pump Valve-in-a-Valve Implantation,” Case Reports, The Society of Thoracic Surgeons, 2008.
Walther et al., “Valve-in-a-Valve Concept for Transcatheter Minimally Invasive Repeat Xenograph Implantation,” Preclinical Studies, Journal of the American College of Cardiology, 2007.
Walther T, Dehdashtian MM, Khanna R, Young E, Goldbrunner PJ, Lee W. Trans-catheter valve-in-valve implantation: in vitro hydrodynamic performance of the SAPIEN+cloth trans-catheter heart valve in the Carpentier-Edwards Perimount valves. Eur J Cardiothorac Surg. 2011;40(5):1120-6. Epub Apr. 7, 2011.
Webb et al., “Mitral Valve in Valve,” TCT Sep. 2009, Live Case: 30 Minutes, St. Paul's Hospital/University of British Columbia.
Webb et al., “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves,” Journal of the American Heart Association, 11, Apr. 27, 2010.
Weger et al., “First-in-Man Implantation of a Trans-Catheter Aortic Valve in a Mitral Annuloplasty Ring: Novel Treatment Modality for Failed Mitral Valve Repair,” European Journal of Cardio-Thoracic Surgery 39, 1054-1056, 2011.
Wenaweser et al., “Percutaneous Aortic Valve Replacement for Severe Aortic Regurgitation in Degenerated Bioprosthesis: The First Valve Procedure Using Corevalve Revalving System,” Catheterization and Cardiovascular Interventions, 70:760-764, 2007.
Wheatley, “Valve Prostheses,” Operative Surgery, 4th ed. pp. 415-424. 1986.
Walther, et al., “Trans-catheter valve-in-valve implantation: in vitro hydrodynamic performance of the SAPIEN + cloth trans-catheter heart valve in the Carpentier-Edwards Perimount valves,” European Journal of Cardio-thoracic Surgery, 40 (2011) 1120-1126, Sep. 23, 2010.
Related Publications (1)
Number Date Country
20220378572 A1 Dec 2022 US
Provisional Applications (2)
Number Date Country
62073088 Oct 2014 US
62049432 Sep 2014 US
Divisions (1)
Number Date Country
Parent 14850822 Sep 2015 US
Child 16029355 US
Continuations (2)
Number Date Country
Parent 16877366 May 2020 US
Child 17817635 US
Parent 16029355 Jul 2018 US
Child 16877366 US